Dr Jason Hlozek

Investigator I AI/ML Drug Discovery

Jason Hlozek obtained his B.Sc. in Chemistry and Computer Science from the University of Cape Town (UCT) in 2014, followed by a B.Sc. Honours in Computer Science in 2015.

He then joined the Bioanalytical and Vaccine Research Group from 2016 to 2020, where he obtained his PhD in Chemistry under the supervision of Prof. Neil Ravenscroft (Chemistry) and co-supervision of Prof. Michelle Kuttel (Chemistry). His PhD work focused on the computational modelling of bacterial carbohydrate antigens to advance the understanding of vaccine cross-protection phenomena to promote the rational design of optimal multivalent vaccines. He has authored several publications on the conformational analysis of polysaccharides corresponding to strains of Neisseria meningitidis and Shigella flexneri, pathogenic bacteria that predominantly burden low-income settings.

Jason is passionate about interdisciplinary research and work that will make a positive and tangible impact on society. In May 2021, he joined the Kelly Chibale academic group and H3D as a postdoctoral research fellow, pursuing research in the field of artificial intelligence (AI) and Machine Learning (ML) with the application of accelerating drug discovery and development.